title: Interventions to improve inpatient osteoporosis management following first osteoporotic fracture: the PREVENT project.
abstract: OBJECTIVE
  To establish a protocol for the treatment of fragility fractures in the hospital setting based on treatment of osteoporosis.
  
  
  METHODS
  An intervention protocol was implemented in patients with fragility fractures based on (1) indicating the diagnosis of osteoporotic fracture in the summary of discharge; (2) "lifestyle recommendations"; and (3) therapy for osteoporosis. Thirty-one hospitals were involved and they were informed of the importance of protocol compliance. In the first phase, a retrospective study was conducted to establish the number of low-energy fractures treated and the percentage of them that had complied with the protocol (n = 887). Then, prospectively, the same data were collected for the patients managed for 1 year (n = 6,826) in three sections of 4-month intervals.
  
  
  RESULTS
  The percentage of compliance increased from 8.2 to 57.2% in the first point, from 12.6 to 42.4% in the second, and from 10.3 to 43.2% in the third.
  
  
  CONCLUSIONS
  The implementation of programs to improve osteoporosis treatment is very useful for ensuring adherence in the management of osteoporosis following admission due to fragility fracture.
authors.affiliation: University Hospital Reina Sofia, Mejorana 45, 14012 Cordoba, Spain. pcarpinterob@medynet.com
authors.forename: Pedro
authors.initials: P
authors.lastname: Carpintero
authors.forename: Enrique
authors.initials: E
authors.lastname: Gil-Garay
authors.forename: Daniel
authors.initials: D
authors.lastname: Hernández-Vaquero
authors.forename: Humbert
authors.initials: H
authors.lastname: Ferrer
authors.forename: Luis
authors.initials: L
authors.lastname: Munuera
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002116:Calcitonin / Q000008:administration & dosage; D002118:Calcium / Q000008:administration & dosage; D002985:Clinical Protocols; D004164:Diphosphonates / Q000008:administration & dosage; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000628:therapy*; D019983:Guideline Adherence; D006760:Hospitalization; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D011446:Prospective Studies; D012189:Retrospective Studies; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium